IP Library Granted Patent US 8,492,412
Granted Patent B2
US 8,492,412 · App. 12/673,304 · Granted Jul 23, 2013

Gel containing pirfenidone

Inventors: José Agustín Rogelio Magaña Castro (Mexico City, MX); Laura Vázquez Cervantes (Mexico City, MX); Juan Socorro Armendáriz Borunda (Mexico City, MX)
Assignee: Cell Therapy and Technology, S.A. De C.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,492,412
App. No.
12/673,304
Granted
Jul 23, 2013
Kind
B2
Abstract

The invention relates to a gel composition containing pirfenidone, which is advantageous over other cutaneously administered pharmaceutical forms known in the prior art and which can be used in treatment for the restoration of tissues with fibrotic lesions and for the prevention of fibrotic lesions.

Claims (9)

1. A composition of Pirfenidone gel consisting of 8% Pirfenidone, 0.5% of a viscous agent, 20% of a solubilizer, 11.5% of a non ionic solubilizer, 0.5% of a conserving agent, 0.5% of a neutralizer agent and 59% of purified water.

2. The composition of claim 1 , wherein

(a) the viscous agent is selected from the group consisting of a Carbomer 940 (MR), Carbomer Homopolymer Type A, a cellulose derivative, a gum, and a poloxamer;

(b) the solubilizer is selected from the group consisting of N-methylpyrrolidone, ethyl alcohol, and propylene glycol;

(c) the conserving agent is selected from the group consisting of diazolidinyl urea, iodopropynyl butylcarbamate, methylparaben, propylparaben, and mixes of these conserving agents;

(d) the neutralizer agent is selected from the group consisting of primary, secondary and tertiary aliphatic amines of the mono-, bi-, and triethanolamine type, and a hydroxide alkaline metal.

3. The composition of claim 2 , wherein the viscous agent is Carbomer 940 (MR), the solubilizer is N-methylpyrrolidone, the conserving agent is diazolidinyl urea, and the neutralizer agent is triethanolamine.

4. The composition of claim 2 , wherein the hydroxide alkaline metal is sodium hydroxide.

5. The composition of claim 2 , wherein the viscous agent is Carbomer 940 (MR), the solubilizer is N-methylpyrrolidone, the conserving agent is iodopropynyl butylcarbamate, and the neutralizer agent is triethanolamine.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2020
From: CELL THERAPY TECHNOLOGY S.A. DE C.V.
To: EXCALIBUR PHARMACEUTICALS, INC.
Reel/Frame 053418/0628 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND AND THIRD INVENTORS PREVIOUSLY RECORDED AT REEL: 024296 FRAME: 0710. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2016
From: MAGANA CASTRO, JOSE AGUSTIN ROGELIO; VAZQUEZ CERVANTES, LAURA; ARMENDARIZ BORUNDA, JUAN SOCORRO
To: CELL THERAPY AND TECHNOLOGY, S.A. DE C.V.
Reel/Frame 039198/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2010
From: MAGANA CASTRO, JOSE AGUSTIN ROGELIO; CERVANTES, LAURA VAZQUEZ; BORUNDA, JUAN SOCORRO ARMENDARIZ
To: CELL THERAPY AND TECHNOLOGY, S.A. DE C.V.
Reel/Frame 024296/0710 →
Priority Claims (1)
MX MX/A/2007/009796 · Aug 14, 2007 · national
Continuity (1)
Related Publication 20110224265A1 · Sep 15, 2011